On August 6, 2024, BeyondSpring Inc.'s subsidiary, SEED Therapeutics, entered a strategic research collaboration with Eisai for $24 million, which includes potential milestone payments of up to $1.5 billion.
AI Assistant
BEYONDSPRING INC
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.